Every year, hundreds of thousands of patients around the world wait for a kidney transplant that may never come. Kidney failure — the irreversible loss of kidney function — requires either long-term dialysis or a successful transplant to sustain life. While dialysis can maintain a patient for years, kidney transplantation offers significantly better outcomes: improved quality of life, reduced cardiovascular risk, and greater long-term survival. Yet the gap between the number of patients who need a transplant and the number who actually receive one remains vast, and it is growing.
According to data from the 2022 Global Observatory on Donation and Transplantation (GODT), more than 2.5 million patients worldwide require kidney transplantation, while fewer than 150,000 transplants are performed each year — fewer than one in sixteen patients receiving the transplant they need. This disparity represents one of the most urgent unresolved challenges in global nephrology. The International Society of Nephrology (ISN) has placed this crisis at the center of its global advocacy efforts, working to expand donation frameworks, reform policy, and build transplant capacity in under-resourced settings.
The Scale of the Problem: A Global Perspective
The shortage of donor kidneys is not a problem confined to any single region. It is a truly global crisis, though its severity varies dramatically between high-income and low- and middle-income countries (LMICs). In wealthy nations with well-established health systems, transplant waiting lists are long but structured. In LMICs, the situation is often far more dire: transplantation may be entirely inaccessible, and many patients with end-stage kidney disease never even reach a transplant waiting list.
ISN (International Society of Nephrology) has documented this reality through collaborative research efforts. The Global Kidney Health Atlas, published in 2019 in Kidney International Supplements, gathered data from ISN member countries around the world. The findings revealed that:
- Living donor transplantation rates below 5 per million population are reported in more than half of participating countries.
- Deceased donor transplant programs are entirely absent in more than 60 nations.
- Access to transplantation is closely tied to income level, national infrastructure, and the existence of supportive legal frameworks for organ donation.
These numbers paint a clear picture: the shortage of donor kidneys is not merely a biological or medical problem. It is shaped by legislation, culture, economics, and the uneven distribution of medical expertise across the globe. Addressing it requires solutions that go beyond the operating room.
Why Kidney Transplantation Remains the Best Treatment Option
To understand why this shortage matters so deeply, it is important to appreciate what kidney transplantation means for patients. The kidneys perform a range of critical functions: filtering waste products from the blood, regulating fluid balance and blood pressure, producing hormones that support red blood cell production, and maintaining the chemical environment necessary for normal cell function.
When the kidneys fail permanently — end-stage kidney disease (ESKD) — patients require renal replacement therapy to survive. Dialysis artificially removes waste products from the blood, but it is burdensome: most patients require three or more sessions per week, each lasting several hours, with significant fatigue, dietary restrictions, and elevated risks of cardiovascular disease and infection.
Kidney transplantation restores more normal kidney function and eliminates the need for regular dialysis. Studies consistently show that transplanted patients live longer, experience fewer hospitalizations, and report substantially better quality of life. The benefit is especially pronounced for younger patients and those with diabetes, who carry particularly high risks on long-term dialysis. Expanding access to transplantation is therefore not merely a matter of comfort — it is a matter of life and death for millions of patients.
Expanding the Donor Pool: Strategies and Approaches
Expanded Criteria Donors
One of the most important strategies for increasing the supply of transplantable kidneys is making use of organs that might previously have been declined. Expanded criteria donor (ECD) kidneys come from deceased donors who are older — typically over 60 years of age — or who have certain medical conditions such as hypertension or mildly reduced kidney function. These kidneys carry a somewhat higher risk of suboptimal function after transplantation, but the evidence strongly supports their use in many patients.
Research published in the American Journal of Transplantation, including analysis of UNOS/OPTN data by Merion and colleagues (2005), demonstrated that for most patients on the transplant waiting list, receiving an ECD kidney still offers a significant survival advantage compared to remaining on dialysis while waiting for an ideal organ. This finding has been instrumental in shifting clinical attitudes toward more liberal acceptance of ECD kidneys, particularly for older recipients who may not survive a lengthy wait for a standard criteria donor organ.
The International Society of Nephrology has supported evidence-based frameworks for the acceptance of ECD kidneys, recognizing that the perfect should not be the enemy of the good when patient lives are at stake.
Donation After Circulatory Death
Donation after circulatory death (DCD) refers to organ retrieval from donors whose hearts have stopped beating, as distinct from the more traditional donation after brain death (DBD). DCD programs significantly expand the pool of available deceased donor kidneys, particularly in countries where brain-death donation is limited by legal constraints or low rates of eligible donors.
DCD kidneys are associated with a higher rate of delayed graft function — a temporary period after transplantation during which the kidney does not work immediately and the patient may still require short-term dialysis. However, long-term outcomes for DCD kidney transplants are generally comparable to those from DBD donors when appropriate protocols are followed. ISN has endorsed the expansion of DCD programs in countries developing or reforming their organ procurement infrastructure, viewing DCD as a critical tool for closing the gap between supply and demand.
Living Donor Transplantation
Living donor transplantation — in which a healthy individual donates one of their two kidneys to a patient in need — offers a number of advantages over deceased donor transplantation. Living donor kidneys typically function immediately after transplantation, have better long-term survival rates, and can be transplanted in a planned, elective manner. Donation can take place between biologically related individuals, emotionally related individuals such as spouses, or altruistic strangers. The safety of living donation is well established: carefully screened donors face a very small lifetime increase in the risk of kidney disease, and long-term outcomes for donors are generally excellent.
Despite these advantages, living donation rates remain very low in many countries, falling below 5 per million population in more than half of ISN member nations. Cultural attitudes, lack of public awareness, legal restrictions, and concerns about donor welfare all contribute to this underutilization.
Kidney Paired Donation: Solving the Compatibility Problem
One of the most innovative approaches to expanding living donor transplantation is kidney paired donation (KPD), also known as kidney exchange. KPD addresses a fundamental challenge: a willing living donor may not be biologically compatible with their intended recipient — for example, due to blood type mismatch or the presence of specific immune antibodies. Without intervention, such a donor-recipient pair would be unable to proceed with transplantation.
KPD programs solve this problem by matching incompatible pairs with one another. In a simple two-way exchange, the donor of Pair A donates to the recipient of Pair B, and the donor of Pair B donates to the recipient of Pair A. More complex multi-way chains — particularly those initiated by altruistic non-directed donors — can extend across many pairs simultaneously, greatly increasing the number of successful transplants.
The effectiveness of KPD programs has been demonstrated in practice. The national KPD program developed in Canada, described by Gentry and colleagues in the journal Transplantation (2009), showed that multi-way chain exchanges initiated by non-directed donors significantly increase transplantation rates among incompatible pairs. Similar programs have been developed in the United States, the United Kingdom, the Netherlands, and other countries, each contributing to measurable increases in living donor transplantation rates.
An emerging frontier is international KPD pooling — collaborative programs that allow incompatible pairs from different countries to be matched across borders. ISN has identified international KPD pooling as a promising strategy for increasing matching efficiency, particularly for patients with rare blood types or complex immune profiles. Such programs require harmonization of legal frameworks and cross-border logistics, but their potential to expand access to transplantation is substantial.
Consent Systems and Organ Allocation: The Policy Dimension
Opt-In Versus Opt-Out Consent
Beyond the medical and logistical strategies for expanding the donor pool, the policies that govern organ donation and allocation play a decisive role in determining how many transplants are performed. Deceased donor organ donation systems generally operate under one of two consent models:
- Opt-in (explicit consent): Individuals must actively register their willingness to donate organs after death. Countries with opt-in systems include the United States, Canada, and Germany.
- Opt-out (presumed consent): All individuals are assumed to have consented to donation unless they have explicitly registered their objection. Countries with opt-out systems include Spain, France, and several other European nations.
Spain is frequently cited as a global model for deceased donor transplantation, consistently achieving donation rates among the highest in the world. While Spain’s opt-out consent system is often credited for this success, experts generally agree that organizational factors — a well-resourced network of hospital transplant coordinators and proactive communication with donor families — are equally important. The International Society of Nephrology has advocated for context-sensitive policy reform, recognizing that effective programs combine appropriate legal structures with trained personnel, public trust, and robust institutional support.
Transparent Allocation Algorithms
Once an organ becomes available, allocation algorithms determine which patient on the waiting list should receive it, taking into account blood type compatibility, immunological matching, waiting time, geographical proximity, and medical urgency. These algorithms have a profound impact on equity. ISN has consistently called for transparent, evidence-based allocation frameworks that prioritize medical need while actively addressing disparities in access. A position paper on transplantation access in LMICs, by Garcia-Garcia and colleagues (Kidney International, 2019), outlined a roadmap for developing sustainable transplant programs — addressing the legal, financial, and capacity-building requirements necessary for safe procurement and equitable recipient selection.
Challenges in Low- and Middle-Income Countries
The global shortage of donor kidneys is most acutely felt in LMICs, where transplant infrastructure is often rudimentary or absent. The barriers these countries face are multiple and interrelated:
- Legal frameworks: Many LMICs lack clear, comprehensive legislation governing organ donation, procurement, and allocation. Without legal clarity, transplant programs cannot operate safely or transparently.
- Financial constraints: Transplantation is a resource-intensive undertaking. Surgical facilities, trained personnel, immunosuppressive medications, and post-transplant monitoring all require sustained funding that is frequently unavailable in low-resource settings.
- Workforce and training: Transplant surgery and nephrology require specialized expertise. Many LMICs face a critical shortage of trained transplant surgeons, nephrologists, and transplant coordinators.
- Cultural and religious factors: Attitudes toward organ donation vary widely across cultures and religious traditions. In some communities, concerns about the integrity of the body after death present significant barriers to deceased donor donation.
- Infrastructure: Cold chain logistics, organ preservation facilities, and cross-regional coordination networks are prerequisites for an effective deceased donor program — and are frequently absent or inadequate in LMICs.
ISN (International Society of Nephrology) has made supporting kidney care in LMICs a central pillar of its mission. Through education, advocacy, and collaborative research, ISN helps member countries build the legal, financial, and professional foundations needed to develop sustainable transplant programs, including targeted fellowships and partnerships with regional nephrology societies.
Key Indicators: Global Kidney Transplantation at a Glance
| Indicator | Global Estimate / Finding |
|---|---|
| Patients requiring kidney transplantation globally | Over 2.5 million (GODT 2022) |
| Kidney transplants performed annually | Fewer than 150,000 per year |
| Countries with no deceased donor transplant program | Over 60 nations |
| Countries with living donor rate below 5 per million population | More than half of ISN member countries |
| Proportion of patients in need who receive a transplant annually | Fewer than 1 in 16 |
| ECD kidney transplantation vs. dialysis wait (survival benefit) | Demonstrated for most wait-listed patients (Merion et al., 2005) |
The Road Ahead: ISN’s Role in Driving Change
The International Society of Nephrology occupies a unique position in the global effort to address the kidney donor shortage. As a leading professional organization representing nephrologists, researchers, and kidney health advocates across more than 130 countries, ISN brings both scientific credibility and global reach to this challenge.
ISN’s strategy is multi-pronged: supporting the generation and dissemination of evidence through publications such as the Global Kidney Health Atlas; advocating for policy reform at national and international levels; building professional capacity in LMICs through educational programs and fellowships; and promoting innovation in transplantation practice, including the expansion of ECD and DCD programs and the development of international KPD networks.
Progress is possible — and is already being made in countries that have committed to systemic, sustained reform. The models exist. The evidence is available.
Conclusion
The global shortage of donor kidneys for transplantation is one of the defining challenges of modern nephrology. With more than 2.5 million patients requiring transplantation and fewer than 150,000 transplants performed each year,
the gap between need and availability is both vast and deeply consequential — measured not in statistics alone, but in lives shortened and quality of life diminished for patients around the world.
Addressing this shortage demands action on multiple fronts: expanding the use of ECD and DCD organs, growing living donor programs, scaling kidney paired donation nationally and internationally, reforming consent and allocation policies, and building transplant capacity in underserved regions. Each of these strategies has demonstrated real-world effectiveness and is supported by evidence and endorsed by the International Society of Nephrology.
The work of ISN in documenting global disparities, advocating for equitable access, and building professional capacity in LMICs represents a critical investment in the future of kidney health worldwide. Closing the donor gap will require sustained commitment from governments, health systems, professional societies, and communities around the world. But with the right policies, the right investments, and the right collective will, it is a goal firmly within reach.